Drug Use Investigation Of Gabapentin

Status Completed

Clinical Trial Summary

The objective of the this surveillance is to collect information about 1)adverse drug reactions not expected from the LPD (unknown adverse drug reactions), 2) the incidence of adverse drug reactions in this surveillance, and 3) factors considered to affect the safety and/or efficacy of this drug.

Clinical Trial Description

All the patients whom an investigator prescribes the first Gabapentin should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random. ;

Study Design

Related Conditions & MeSH terms

Epilepsies, Partial

Clinical Trial Details

NCT number	NCT00567268
Study type	Observational
Source	Pfizer
Contact
Status	Completed
Phase
Start date	August 2007
Completion date	May 2014

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT00524030` - Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures	Phase 3
Completed	`NCT00143143` - Pregabalin Open-Label Extension Trial in Patients With Partial Seizures	Phase 3
Completed	`NCT00771927` - Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures	N/A
Completed	`NCT00236873` - A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.	Phase 2
Completed	`NCT01745952` - Treatment of Difficult to Control Focal Epilepsy With Repetitive Transcranial Magnetic Stimulation (rTMS)	N/A
Completed	`NCT00772603` - Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures	Phase 3
Completed	`NCT00280696` - A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures	Phase 3
Completed	`NCT00643136` - A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures	Phase 3
Completed	`NCT00230698` - A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure	Phase 3
Completed	`NCT00072813` - MRI in Autosomal Dominant Partial Epilepsy With Auditory Features	N/A
Enrolling by invitation	`NCT04309812` - Transcranial Direct Current to Treat Epilepsy at Home	Early Phase 1
Completed	`NCT00620555` - A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures	Phase 3
Withdrawn	`NCT00422110` - A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures	Phase 2/Phase 3
Completed	`NCT00448916` - Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures	Phase 3
Completed	`NCT00210522` - An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy	Phase 2
Completed	`NCT00236886` - Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients	Phase 3
Completed	`NCT00236860` - A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures	Phase 2
Active, not recruiting	`NCT03689114` - Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)	Phase 4
Completed	`NCT01098162` - Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug	N/A
Completed	`NCT05273398` - Effects of Diazepam on RNS Detections	Phase 4